Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Person

Danny Cohn

Tracked across 1 events · 6 articles · First seen Jun 01, 2026 · Last active Jun 01, 2026

Sentiment
0
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
4 0
Tech
Coya Therapeutics announced that data from its global Phase 3 HAELO clinical trial of Lonvoguran ziclumeran, a CRISPR-based gene editing therapy for hereditary angioedema (HAE), will be presented at the European Academy of Allergy and…
Impact: Danny Cohn, M.D., Ph.D., will be presenting the late-breaking oral presentation on the HAELO Phase 3 study of Lonvoguran ziclumeran.
Jun 01, 2026 · 6 articles
NEWSDESK
Track Danny Cohn live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.